Skip to main navigation Skip to search Skip to main content

Dendritic cell surface calreticulin is a receptor for NY-ESO-1: Direct interactions between tumor-associated antigen and the innate immune system

  • Gang Zeng*
  • , Michael E. Aldridge
  • , Xiaoli Tian
  • , Daniel Seiler
  • , Xiaolong Zhang
  • , Yusheng Jin
  • , Jianyu Rao
  • , Weidong Li
  • , Dequan Chen
  • , Marlyn P. Langford
  • , Chris Duggan
  • , Arie S. Belldegrun
  • , Steven M. Dubinett
  • *Corresponding author for this work
  • University of California at Los Angeles
  • ProtTech, Inc.
  • LSU Health Sciences Center - Shreveport

Research output: Contribution to journalArticlepeer-review

56 Citations (Scopus)

Abstract

How the immune system recognizes endogenously arising tumors and elicits adaptive immune responses against nonmutated tumor-associated Ags is poorly understood. In search of intrinsic factors contributing to the immunogenicity of the tumor-associated Ag NY-ESO-1, we found that the NY-ESO-1 protein binds to the surface of immature dendritic cells (DC), macrophages, and monocytes, but not to that of B cells or T cells. Using immunoprecipitation coupled with tandem mass spectrometry, we isolated DC surface calreticulin as the receptor for NY-ESO-1. Calreticulin Abs blocked NY-ESO-1 binding on immature DC and its cross-presentation to CD8+ T cells in vitro. Calreticulin/NY-ESO-1 interactions provide a direct link between NY-ESO-1, the innate immune system, and, potentially, the adaptive immune response against NY-ESO-1.

Original languageEnglish
Pages (from-to)3582-3589
Number of pages8
JournalJournal of Immunology
Volume177
Issue number6
DOIs
Publication statusPublished - 15 Sept 2006
Externally publishedYes

Cite this